These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36648148)

  • 1. Immunohistochemical analysis of expression of VEGFR2, KIT, PDGFR-β, and CDK4 in canine urothelial carcinoma.
    Setyo LC; Donahoe SL; Shearer PL; Wang P; Krockenberger MB
    J Vet Diagn Invest; 2023 Mar; 35(2):109-115. PubMed ID: 36648148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma.
    Walters L; Martin O; Price J; Sula MM
    Vet Comp Oncol; 2018 Mar; 16(1):E117-E122. PubMed ID: 28884928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor tyrosine kinase expression and phosphorylation in canine nasal carcinoma.
    Hocker SE; Higginbotham ML; Schermerhorn T; Henningson J
    Res Vet Sci; 2017 Dec; 115():484-489. PubMed ID: 28783596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of receptor tyrosine kinase activation and biological activity of toceranib phosphate in canine urothelial carcinoma cell lines.
    Korec DI; Louke DS; Breitbach JT; Geisler JA; Husbands BD; Fenger JM
    BMC Vet Res; 2021 Oct; 17(1):320. PubMed ID: 34600548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-kit, flt-3, PDGFR-β, and VEGFR2 expression in canine adrenal tumors and correlation with outcome following adrenalectomy.
    Harding K; De Mello Souza CH; Shiomitsu K; Maxwell E; Bertran J
    Can J Vet Res; 2021 Oct; 85(4):279-284. PubMed ID: 34602732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma.
    Urie BK; Russell DS; Kisseberth WC; London CA
    BMC Vet Res; 2012 May; 8():67. PubMed ID: 22630170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PDGFR-β and Kit in canine anal sac apocrine gland adenocarcinoma using tissue immunohistochemistry.
    Brown RJ; Newman SJ; Durtschi DC; Leblanc AK
    Vet Comp Oncol; 2012 Mar; 10(1):74-9. PubMed ID: 22235855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of platelet-derived growth factor receptor-α/ß, vascular endothelial growth factor receptor-2, c-Abl, and c-Kit in canine granulomatous meningoencephalitis and necrotizing encephalitis.
    Song JH; Yu DH; Hwang TS; Seung BJ; Sur JH; Kim YJ; Jung DI
    Vet Med Sci; 2020 Nov; 6(4):965-974. PubMed ID: 32585777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor Tyrosine Kinase Expression Profiles in Canine Cutaneous and Subcutaneous Mast Cell Tumors.
    Thompson JJ; Morrison JA; Pearl DL; Boston SE; Wood GA; Foster RA; Coomber BL
    Vet Pathol; 2016 May; 53(3):545-58. PubMed ID: 26459517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemistry Screening of Different Tyrosine Kinase Receptors in Canine Solid Tumors-Part I: Proposal of a Receptor Panel to Predict Therapies.
    Dos Anjos DS; Civa PAS; Werner J; Vicente IST; Fonseca-Alves CE
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the therapeutic potential of masitinib and expression of its specific targets c-Kit, PDGFR-α, PDGFR-β, and Lyn in canine prostate cancer cell lines.
    Klose K; Packeiser EM; Granados-Soler JL; Hewicker-Trautwein M; Murua Escobar H; Nolte I
    Vet Comp Oncol; 2022 Sep; 20(3):641-652. PubMed ID: 35384248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of HER2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder.
    Tsuboi M; Sakai K; Maeda S; Chambers JK; Yonezawa T; Matsuki N; Uchida K; Nakayama H
    Vet Pathol; 2019 May; 56(3):369-376. PubMed ID: 30612533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of lymphocyte-specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients.
    Pinard CJ; Stegelmeier AA; Bridle BW; Mutsaers AJ; Wood RD; Wood GA; Woods JP; Hocker SE
    Vet Comp Oncol; 2022 Jun; 20(2):427-436. PubMed ID: 34797014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGFR-α, PDGFR-β, VEGFR-2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines.
    Gattino F; Maniscalco L; Iussich S; Biasato I; Martano M; Morello E; Gola C; Millán Ruiz Y; Saeki N; Buracco P; Martín de Las Mulas J; De Maria R
    Vet Rec; 2018 Aug; 183(7):221. PubMed ID: 29440590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Biomarkers Between Hepatic Tumors in Rat Models and a Dog.
    Kim S; Kim Y; Kim SE; Kim HJ
    In Vivo; 2023; 37(1):252-261. PubMed ID: 36593028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of VEGFR and PDGFR-α/-β in 187 canine nasal carcinomas.
    Gramer I; Killick D; Scase T; Chandry D; Marrington M; Blackwood L
    Vet Comp Oncol; 2017 Sep; 15(3):1041-1050. PubMed ID: 27278115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of p63, Ki67 and β-catenin in canine transitional cell carcinoma and polypoid cystitis of the urinary bladder.
    Hanazono K; Nishimori T; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Uchide T
    Vet Comp Oncol; 2016 Sep; 14(3):263-9. PubMed ID: 24758385
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Sakai K; Maeda S; Saeki K; Yoshitake R; Goto-Koshino Y; Nakagawa T; Nishimura R; Yonezawa T; Matsuki N
    Vet Pathol; 2020 Jan; 57(1):56-65. PubMed ID: 31640537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective detection of BRAF
    Aeschlimann L; Kehl A; Guscetti F; Posthaus C; Aupperle-Lellbach H; Rottenberg S; de Brot S
    Vet Comp Oncol; 2024 Jun; 22(2):295-302. PubMed ID: 38659202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.
    Schmandt RE; Broaddus R; Lu KH; Shvartsman H; Thornton A; Malpica A; Sun C; Bodurka DC; Gershenson DM
    Cancer; 2003 Aug; 98(4):758-64. PubMed ID: 12910520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.